Skip to content ↓

Retirement notes

STATEMENTS ISSUED

The personalized statements for those eligible for the Special Retirement Incentive Program have been distributed through Institute mail. The statement shows benefit estimates and the effects of the incentive enhancements on retirement benefits. A guide to the MIT RetireLine is also included in the statement to assist employees in making their incentive program elections.If you were notified by the Benefits Office that you are eligible for the Special Retirement Incentive Program and you have not received a statement, call the special hotline, 258-7777, to request one. When you call, please leave your name, office or lab address, office or lab telephone number, and your MIT ID number. Your statement will be sent out to you promptly.

CORRECTION DEADLINE

Today is the last day to make any corrections to the personal information section of the personalized statement you received last week. If you need to make any corrections, please call the hotline at 258-7777. If the corrections affect the estimated benefits shown on your statement, a new statement will be issued to you promptly.Please make sure that you have called the MIT RetireLine to acknowledge receipt of your statement. You can call the MIT RetireLine at 1 (800) 250-2859.

ERRATUM

The telephone number for Social Security in last week's Q&A was wrong. The correct number is 1 (800) 772-1213.

A version of this article appeared in MIT Tech Talk on March 6, 1996.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story